) The VCC DNA Analysis Core Facility provides fast, inexpensive, user-friendly DNA analysis services to the members of the Vermont Cancer Center. Primary services offered include DNA sequencing, DNA fragment analysis and real-time quantitative PCR. The Facility contains an ABI 373XL automated sequencer with stretch plate capability, 48 lane upgrade and a recent (September, 1999) filter wheel upgrade to enable state-of-the-art chemistry, enhanced run length and optimal signal to noise ratio for sequence runs. The facility also contains an ABI 310 Prism Genetic Analyzer. Wet laboratory dedicated to the facility is approximately 300 s.f. within VCC laboratories in the Medical Alumni Facility. In addition to the labs, an adjacent office is used for sample intake and high-performance user workstations enabling clients to conduct data review and analyses on-site with special software and with direct access to facility staff (software including Genotyper, Sequence Navigator, AutoAssembler, DNASTAR, Primer Express and Sequencher). A Luminex 100 instrument was acquired in April 1999 enabling high-throughput DNA hybridizations (or antigen-antibody or ligand-receptor reactions) on styrofoam beads. In October 1999 the Facility acquired an ABI 7700 (TaqMan) instrument to allow real-time quantitative PCR experiments to be performed by VCC members. The Facility performs over 10,000 lanes of sequence per year and over 8,000 cycle sequencing reactions. Over 80 percent of the cycle sequencing reactions and over 65 percent of the lanes of sequence performed are for VCC members in support of qualifying peer-reviewed studies. The Facility performs other important functions in support of VCC research including: sponsoring seminars and Open House events, tutorials, obtaining bulk prices on reagents, and providing troubleshooting or assistance designing experiments utilizing new technologies. The Facility is user-friendly and responsive to VCC member needs and requests, including new techniques and technologies; a User Group meets quarterly with the facility Director, Manager and VCC Administrator to provide feedback on services, costs, availability, and need for new technologies or instrumentation. Mr. Hunter, the Facility Manager, chairs the VCC Shared Resource Committee and is a member of the VCC Executive Committee.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA022435-18
Application #
6436432
Study Section
Project Start
1978-08-01
Project End
2005-11-30
Budget Start
1998-10-01
Budget End
1999-09-30
Support Year
18
Fiscal Year
2001
Total Cost
$78,870
Indirect Cost
Name
University of Vermont & St Agric College
Department
Type
DUNS #
066811191
City
Burlington
State
VT
Country
United States
Zip Code
05405
Kelemen, Linda E; Abbott, Sarah; Qin, Bo et al. (2017) Cigarette smoking and the association with serous ovarian cancer in African American women: African American Cancer Epidemiology Study (AACES). Cancer Causes Control 28:699-708
Long, Patrick M; Tighe, Scott W; Driscoll, Heather E et al. (2015) Acetate supplementation as a means of inducing glioblastoma stem-like cell growth arrest. J Cell Physiol 230:1929-43
Tsen, Andrew R; Long, Patrick M; Driscoll, Heather E et al. (2014) Triacetin-based acetate supplementation as a chemotherapeutic adjuvant therapy in glioma. Int J Cancer 134:1300-10
Wagner, Darcy E; Bonenfant, Nicholas R; Parsons, Charles S et al. (2014) Comparative decellularization and recellularization of normal versus emphysematous human lungs. Biomaterials 35:3281-97
Long, Patrick M; Tighe, Scott W; Driscoll, Heather E et al. (2013) Acetate supplementation induces growth arrest of NG2/PDGFR?-positive oligodendroglioma-derived tumor-initiating cells. PLoS One 8:e80714
Sokocevic, Dino; Bonenfant, Nicholas R; Wagner, Darcy E et al. (2013) The effect of age and emphysematous and fibrotic injury on the re-cellularization of de-cellularized lungs. Biomaterials 34:3256-69
Long, Patrick M; Moffett, John R; Namboodiri, Aryan M A et al. (2013) N-acetylaspartate (NAA) and N-acetylaspartylglutamate (NAAG) promote growth and inhibit differentiation of glioma stem-like cells. J Biol Chem 288:26188-200
Bonenfant, Nicholas R; Sokocevic, Dino; Wagner, Darcy E et al. (2013) The effects of storage and sterilization on de-cellularized and re-cellularized whole lung. Biomaterials 34:3231-45
Murray, Janet M; Messier, Terri; Rivers, Jami et al. (2012) VDJ recombinase-mediated TCR ? locus gene usage and coding joint processing in peripheral T cells during perinatal and pediatric development. J Immunol 189:2356-64
Wallis, John M; Borg, Zachary D; Daly, Amanda B et al. (2012) Comparative assessment of detergent-based protocols for mouse lung de-cellularization and re-cellularization. Tissue Eng Part C Methods 18:420-32

Showing the most recent 10 out of 219 publications